Current practice with vitamin K antagonist therapy.
D000925:Anticoagulants / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D001665:Binding Sites; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D001780:Blood Coagulation Tests; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D007408:Intestinal Absorption; D008099:Liver / Q000378:metabolism; D008134:Long-Term Care; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D011485:Protein Binding; D012008:Recurrence; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D010837:Vitamin K 1 / Q000627:therapeutic use
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D014812:Vitamin K; D010837:Vitamin K 1